4basebio UK Societas's market cap is currently ―. The company's EPS TTM is p-0.509; its P/E ratio is -22.90; 4basebio UK Societas is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 22	Dec 21	Jun 21	Dec 20	Jun 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 5.60M	£ 9.59M	£ 12.06M	£ 15.00M	£ 15.00M
Total Assets	£ 12.38M	£ 14.70M	£ 15.31M	£ 17.81M	£ 17.60M
Total Debt	£ 0.00	£ 1.76M	£ 0.00	£ 1.72M	£ 3.01M
Net Debt	£ -5.60M	£ -7.83M	£ -12.06M	£ -13.28M	£ -11.99M
Total Liabilities	£ 2.90M	£ 3.01M	£ 1.89M	£ 2.35M	£ 17.60M
Stockholders Equity	£ 9.49M	£ 11.70M	£ 13.41M	£ 15.46M	£ 0.00
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

4basebio UK Societas Earnings and Revenue History

Income Statement >

4basebio UK Societas Debt to Assets

Balance Sheet >

4basebio UK Societas Cash Flow

Cash Flow >

4basebio UK Societas Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing